Those who had at least 1 inpatient insurance claim for HIV-related treatment or unrelated treatment with an HIV diagnosis were considered to be living with HIV. Receiving 1 or more opioid ...

Local and state governments can help to address homelessness in the US as just part of a multisector approach to homelessness ...

The FDA has approved an updated indication for upadacitinib (Rinvoq; AbbVie) in inflammatory bowel disease (IBD), allowing its use in adults with moderately to severely active ulcerative colitis or ...

Ken Cohen, MD, FACP, discusses the importance of expanding cognitive screening for seniors.

The recent FDA approval of topical JAK inhibitors for children 2 years or older marks a significant advancement in pediatric atopic dermatitis treatment. Previously approved only for individuals 12 ...

Experts discuss the foundational role of topical therapies in pediatric atopic dermatitis management, highlighting the importance of individualized regimens that balance efficacy and safety, ...

A recent study reveals significant barriers to GLP-1 RA access for diabetes and obesity patients, highlighting racial ...

Experts discuss the importance of initiating blinatumomab treatment for acute lymphoid leukemia in academic centers for ...

The new report from the WHO Global Antimicrobial Resistance and Use Surveillance System is its most extensive, with estimates ...

To help patients navigate access challenges stemming from cuts under President Donald Trump's One Big Beautiful Bill, Brian Mulherin, MD, a hematologist-oncologist at the American Oncology Network, ...

Jenifer Soung, MD, fo Southern California Dermatology, discussed how glucagon-like peptide-1 receptor agonists aid in treating patients with psoriatic disease. Captions are auto-generated.

Energy-based treatments and lasers for skin care have developed tremendously over the past decade, aided by the work of Eliot ...